Interleukin-10 gene polymorphism in bone marrow transplant recipients

Area of Science:

• Immunogenetics
• Transplantation immunology
• Molecular biology

Background:

• Graft-versus-host disease (GVHD) is a major complication following hematopoietic stem cell transplantation (HSCT), even in HLA-matched pairs.
• Minor histocompatibility antigen mismatches and cytokine gene polymorphisms are implicated in GVHD pathogenesis.
• Interleukin-10 (IL-10) possesses immunosuppressive properties, suggesting a potential role in preventing GVHD.

Purpose of the Study:

• To investigate the association between interleukin-10 (IL-10) promoter gene polymorphisms and transplant outcomes.
• To evaluate the risk of acute GVHD in recipients of allogeneic peripheral blood stem cells from HLA-matched sibling donors based on IL-10 genotype.

Main Methods:

• Analysis of three single nucleotide polymorphisms (-1082, -819, -592) in the IL-10 promoter gene.
• Utilized amplification refractory mutation system (ARMS) and PCR-RFLP techniques.
• Enrolled 18 donor-recipient pairs undergoing allogeneic peripheral blood stem cell transplantation.

Main Results:

• The GCC haplotype (1082G/819C/592C) was the most frequent in both donors and recipients.
• No statistically significant correlation was found between the GCC haplotype and the risk of acute GVHD in either donors or recipients (P = .56).

Conclusions:

• IL-10 promoter gene polymorphism is not associated with acute GVHD in patients receiving HSCT from HLA-matched sibling donors.
• Larger cohort studies are required to elucidate the precise role of IL-10 in the post-HSCT immune response.